Global Pharmaceutical Company
  • Home
  • About
    • About Santhera
    • Board of Directors
    • Executive Management
    • Our Vision
  • Patients
    • Our research
      • Duchenne muscular dystrophy
      • Congenital muscular dystrophy
    • Patient stories
  • Health Care Professionals
    • Vamorolone
    • Lonodelestat
    • Raxone in LHON
    • Scientific publications
  • Investors and Media
    • Investor toolbox
      • Share
      • 2017/2022 convertible bond
      • Bond exchange offering
      • Financial reports
      • Share-/Bondholder meetings
      • Analyst coverage
      • Governance
      • Risk factors
      • Investor contact
    • News and Media Center
      • Press releases
      • News subscriptions
      • Company presentations
      • Scientific publications
      • Media contact
    • Corporate calendar
  • Career
    • Career
    • Job openings
© SANTHERA PHARMACEUTICALS ALL RIGHTS RESERVED
  • CONTACT
  • LEGAL
  • COOKIE POLICY
  • IMPRINT
  • SITEMAP
  • DEUTSCH

    • You are now leaving the Santhera Pharmaceuticals corporate website and will visit the website of Santhera Germany.

    OK Cancel